دورية أكاديمية

SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.

التفاصيل البيبلوغرافية
العنوان: SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.
المؤلفون: El-Khoueiry, Anthony, Rankin, Cathryn, Ben-Josef, Edgar, Lenz, Heinz-Josef, Gold, Philip, Hamilton, R., Govindarajan, Rangaswamy, Eng, Cathy, Blanke, Charles
المصدر: Investigational New Drugs; Aug2012, Vol. 30 Issue 4, p1646-1651, 6p
قاعدة البيانات: Complementary Index
الوصف
تدمد:01676997
DOI:10.1007/s10637-011-9719-0